Carson Wealth (CWM LLC)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,615
Closed -$418K 4670
2023
Q3
$418K Sell
3,615
-258
-7% -$27.7K ﹤0.01% 1039
2023
Q2
$398K Buy
3,873
+1,418
+58% +$150K ﹤0.01% 1011
2023
Q1
$268K Sell
2,455
-6,373
-72% -$704K ﹤0.01% 1094
2022
Q4
$1M Sell
8,828
-5,227
-37% -$434K 0.01% 617
2022
Q3
$870K Sell
14,055
-871
-6% -$60.9K 0.01% 591
2022
Q2
$1.19M Sell
14,926
-1,660
-10% -$157K 0.01% 523
2022
Q1
$1.75M Sell
16,586
-3,297
-17% -$321K 0.01% 428
2021
Q4
$2.14M Buy
+19,883
New +$2.17M 0.02% 416
2021
Q2
$1.89M Hold
20,174
0.02% 439
2021
Q1
$1.89M Hold
20,174
0.02% 439
2020
Q4
$1.89M Hold
20,174
0.02% 439
2020
Q3
$1.89M Hold
20,174
0.02% 439
2020
Q2
$1.89M Hold
20,174
0.02% 439
2020
Q1
$1.89M Hold
20,174
0.02% 439
2019
Q4
$1.89M Hold
20,174
0.02% 439
2019
Q3
$1.89M Hold
20,174
0.02% 439
2019
Q2
$1.89M Hold
20,174
0.02% 439
2019
Q1
$1.89M Buy
+20,174
New +$478K 0.02% 439
2018
Q2
Sell
-114
Closed -$2K 1823
2018
Q1
$2K Buy
+114
New +$1.68K ﹤0.01% 1228
2015
Q4
Sell
-457
Closed -$9K 769
2015
Q3
$9K Buy
+457
New +$14.4K ﹤0.01% 461

Other funds holding HZNP

Carson Wealth (CWM LLC)'s HZNP Position: Q4 2023 in Review

Carson Wealth (CWM LLC) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,615 shares — an estimated $418K sold.

Carson Wealth (CWM LLC) first reported a position in HZNP in Q3 2015 and held it in 20 quarters. The position peaked at $2.14M in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Carson Wealth (CWM LLC) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 3,615 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $418K.
  • Carson Wealth (CWM LLC) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 20 quarters.
  • Carson Wealth (CWM LLC)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.14M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2023, filed 1 Feb 2024.